Top Markets
Coin of the day
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Rang în acțiuni #2339
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Preț acțiune
$43.48
Capitalizare de piață
$8.97B
Schimbare (1 zi)
0.37%
Schimbare (1 an)
192.01%
Țară
US
Tranzacționează Immunovant, Inc. (IMVT)

Categorie

Istoricul spliturilor pentru Immunovant, Inc. (IMVT)
Acțiunea Immunovant, Inc. (simbol: IMVT) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 25, 2026.
O acțiune IMVT cumpărată înainte de Aug 25, 2026 este echivalentă astăzi cu 0 acțiuni IMVT.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH